[S-24] Symposium 24

[S-24-1] Safety and clinical outcomes from the PD 1101 trial of AADC gene therapy for Parkinson's disease

^○Christine Chadwick¹, Richardson Mark², Van Larr Amber³, Liang Grace⁴, Meier Andreas⁵, Bankiewicz Krystof⁶, Larson Paul⁷ (1.University of California San Francisco, USA, 2.Massachusetts General Hospital, 3.University of Pittsburgh Medical Center, 4.Neurocrine Biosciences, 5.Voyager Therapeutics,, 6.Ohio State University, 7.University of Arizona)